- Amazon could be getting into healthcare, and the company's reportedly had conversations with generic drugmakers about it,
- It's the latest hint in recent months that Amazon is serious about healthcare. Worry about the prescription drug business being Amazon'd has sent healthcare stocks tumbling, and is even credited with sparking the
- Conversations with generic drugmakers could mean that Amazon is interested in either helping generic drugmakers distribute prescriptions to pharmacies or by selling the generic prescriptions itself.
ADVERTISEMENT
Amazon is reportedly talking to generic drugmakers
Amazon could be getting into healthcare, and the company's reportedly had conversations with generic drugmakers about it, CNBC reports.
ADVERTISEMENT
Recommended articles
We just got another hint about Amazon's ambitions in healthcare.
CNBC reported on Thursday that Amazon has had exploratory talks with the drugmakers Sandoz, the generic drug unit of Novartis, and Mylan.
According to a note from Leerink cited by CNBC, the president of Sandoz "
ADVERTISEMENT
Amazon declined to comment. Sandoz, and Mylan did not immediately respond to a request for comment.
Shares of Mylan were up 3% on Friday, while the wholesalers were slightly down.
FOLLOW BUSINESS INSIDER AFRICA
ADVERTISEMENT
Recommended articles
Offshore sportsbooks and best sports betting sites
Top 5 African cities with the most unaffordable real estate in 2024
US says it is still engaged with West African juntas
Opinion Piece: Accelerating sustainable development goals through better agricultural risk management
Zimbabwe is set to honor Russian victory with a monument
Top cross-border payment companies in Africa on recent global ranking
Studio Monkey in collaboration with Worldwide FM and Gilles Peterson launches initiative to support grassroot music communities
NexaScale marks one-year milestone with visionary initiatives empowering Africa's youth for the future of work
